Sarcoma  >>  esomeprazole  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
esomeprazole / Generic mfg.
REGORA, NCT02800330 / 2015-005784-17: The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib

Completed
4
31
Europe
Esomeprazole 40mg concomitantly, phase B, Esomeprazole 40mg before, phase C, Regorafenib 160mg or 120mg
Erasmus Medical Center
Colorectal Neoplasms, Gastrointestinal Stromal Tumors
02/18
02/18

Download Options